Literature DB >> 21827843

Cell penetrating peptide-mediated systemic siRNA delivery to the liver.

Yasuhiro Hayashi1, Jun Yamauchi, Ikramy A Khalil, Kazuaki Kajimoto, Hidetaka Akita, Hideyoshi Harashima.   

Abstract

The cell-penetrating peptide (CPP) is one of the most attractive tools for efficiently delivering biomolecules to a target organelle. Here, we describe the use of octaarginine (R8)-modified lipid nanoparticles for the efficient and targeted in vivo delivery of siRNA to the liver. In this study, SR-BI (a scavenger receptor class B, member 1) was targeted by this nanoparticle. Our results demonstrate that R8-modified lipid nanoparticles can be used for the efficient and targeted delivery of liver siRNA to induce the specific knock-down of an endogenous gene with minimum liver toxicity and immune response, and that this CPP based technology holds considerable promise for further in vivo biological applications of siRNA.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21827843     DOI: 10.1016/j.ijpharm.2011.07.038

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  14 in total

1.  In vitro-in vivo translation of lipid nanoparticles for hepatocellular siRNA delivery.

Authors:  Kathryn A Whitehead; Jonathan Matthews; Philip H Chang; Farnaz Niroui; J Robert Dorkin; Mariano Severgnini; Daniel G Anderson
Journal:  ACS Nano       Date:  2012-07-06       Impact factor: 15.881

2.  Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA.

Authors:  Skye Zeller; Chang Seon Choi; Pradeep D Uchil; Hong-Seok Ban; Alyssa Siefert; Tarek M Fahmy; Walther Mothes; Sang-Kyung Lee; Priti Kumar
Journal:  Chem Biol       Date:  2014-12-24

3.  Basics and recent advances in peptide and protein drug delivery.

Authors:  Benjamin J Bruno; Geoffrey D Miller; Carol S Lim
Journal:  Ther Deliv       Date:  2013-11

Review 4.  Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.

Authors:  Hua Li; Tung Yu Tsui; Wenxue Ma
Journal:  Int J Mol Sci       Date:  2015-08-18       Impact factor: 5.923

5.  Intracellular nucleic acid delivery by the supercharged dengue virus capsid protein.

Authors:  João Miguel Freire; Ana Salomé Veiga; Thaís M Conceição; Wioleta Kowalczyk; Ronaldo Mohana-Borges; David Andreu; Nuno C Santos; Andrea T Da Poian; Miguel A R B Castanho
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

Review 6.  Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges.

Authors:  Alfredo Erazo-Oliveras; Nandhini Muthukrishnan; Ryan Baker; Ting-Yi Wang; Jean-Philippe Pellois
Journal:  Pharmaceuticals (Basel)       Date:  2012-11-01

7.  New aspects of gene-silencing for the treatment of cardiovascular diseases.

Authors:  Olivia Koenig; Tobias Walker; Nadja Perle; Almuth Zech; Bernd Neumann; Christian Schlensak; Hans-Peter Wendel; Andrea Nolte
Journal:  Pharmaceuticals (Basel)       Date:  2013-07-19

8.  Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model.

Authors:  Ling Yuan; Congyan Liu; Yan Chen; Zhenhai Zhang; Lei Zhou; Ding Qu
Journal:  Int J Nanomedicine       Date:  2013-11-05

9.  Hepatic Monoacylglycerol O-acyltransferase 1 as a Promising Therapeutic Target for Steatosis, Obesity, and Type 2 Diabetes.

Authors:  Yasuhiro Hayashi; Erina Suemitsu; Kazuaki Kajimoto; Yusuke Sato; Afsana Akhter; Yu Sakurai; Hiroto Hatakeyama; Mamoru Hyodo; Noritada Kaji; Yoshinobu Baba; Hideyoshi Harashima
Journal:  Mol Ther Nucleic Acids       Date:  2014-03-18       Impact factor: 10.183

10.  Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA.

Authors:  Peter Järver; Thibault Coursindel; Samir El Andaloussi; Caroline Godfrey; Matthew Ja Wood; Michael J Gait
Journal:  Mol Ther Nucleic Acids       Date:  2012-06-12       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.